Transcriptome Inference and Systematic Approaches to Investigate TCM Compounds With Beneficial Metabolic Effects
Open Access
- 15 July 2026
- journal article
- Published by Wiley in Phytotherapy Research
- Vol. 40 (11) , 6154-6172
Abstract
Obesity is a major risk factor for type 2 diabetes. Some traditional Chinese medicine (TCM) compounds can improve obesity by increasing energy consumption. This study aimed to identify and verify TCM compounds that promote adipose thermogenesis to alleviate obesity via transcriptomic analysis, molecular docking, network pharmacology, and Connectivity Map (CMap) analysis. Thirty‐six TCMs related to adipose tissue thermogenesis were first collected to generate transcriptomic data. Then a ranking method based on integrated transcriptomic data was used to select emodin from the TCM Da Huang for network pharmacology to explore its potential mechanisms and further experimental validation. CMap analysis of thermogenesis signature genes from ProFAT and GEO datasets identified triptolide as another compound for improving obesity through enhanced thermogenesis. In vitro experiments with 3T3‐L1 cells and in vivo experiments with zebrafish were conducted. The results showed that both emodin and triptolide could upregulate the NAD + /NADH ratio, increase AMPK and SIRT1 expression, suppress lipid accumulation, and promote lipolysis, as verified by both in vitro and in vivo experiments. They also upregulated thermogenesis‐related genes (e.g., UCP1, PGC1α, and PRDM16), lipolysis‐related genes (e.g., PKA, ATGL, and HSL), mitochondrial biogenesis‐related genes (e.g., NRF1, NRF2, and TFAM), and β‐oxidation‐related genes (e.g., CPT1α and CPT1β). Meanwhile, they downregulated lipogenesis‐related genes such as FASN, SREBP1, and ACC. These results provide a basis for understanding the effects of emodin and triptolide on obesity. The findings highlight the effectiveness of combined screening approaches in exploring compounds with beneficial metabolic effects.Keywords
Funding Information
- National Natural Science Foundation of China (2024A0505050001)
- National Natural Science Foundation of China (2024A0505050002)
This publication has 63 references indexed in Scilit:
- Why does obesity cause diabetes?Cell Metabolism, 2022
- Endogenous vitamin E metabolites mediate allosteric PPARγ activation with unprecedented co-regulatory interactionsCell Chemical Biology, 2021
- The phytochemical hyperforin triggers thermogenesis in adipose tissue via a Dlat-AMPK signaling axis to curb obesityCell Metabolism, 2021
- Triptolide enhances lipolysis of adipocytes by enhancing ATGL transcription via upregulation of p53Phytotherapy Research, 2020
- Guizhi Fuling Decoction inhibiting the PI3K and MAPK pathways in breast cancer cells revealed by HTS 2 technology and systems pharmacologyComputational and Structural Biotechnology Journal, 2020
- Prediction of Adipose Browning Capacity by Systematic Integration of Transcriptional ProfilesCell Reports, 2018
- Transcriptional regulation of the uncoupling protein-1 geneBiochimie, 2017
- Celastrol Protects against Obesity and Metabolic Dysfunction through Activation of a HSF1-PGC1α Transcriptional AxisCell Metabolism, 2015
- Treatment of Obesity with CelastrolCell, 2015
- AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant MiceCell Metabolism, 2011